{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T05:11:31Z","timestamp":1792300291929,"version":"4.4.0"},"reference-count":43,"publisher":"Oxford University Press (OUP)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2005,2,15]]},"DOI":"10.1093\/hmg\/ddi052","type":"journal-article","created":{"date-parts":[[2005,1,14]],"date-time":"2005-01-14T01:18:03Z","timestamp":1105665483000},"page":"555-563","source":"Crossref","is-referenced-by-count":103,"title":["Functional and genomic approaches reveal an ancient CHEK2 allele associated with breast cancer in the Ashkenazi Jewish population"],"prefix":"10.1093","volume":"14","author":[{"given":"Avraham","family":"Shaag","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Walsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Renbaum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomas","family":"Kirchhoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khedoudja","family":"Nafa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stacey","family":"Shiovitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica B.","family":"Mandell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piri","family":"Welcsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming K.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan","family":"Ellis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth","family":"Offit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ephrat","family":"Levy-Lahad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary-Claire","family":"King","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2005,1,13]]},"reference":[{"key":"key\n\t\t\t\t20171011160002_DDI052C1","unstructured":"Parkin, D.M., Whelan, S.L., Ferlay, J., Teppo, L. and Thomas, D.B. ( 2002 ) Cancer Incidence in Five Continents Vol. VIII. International Agency for Research on Cancer, IARC Scientific Publications No. 155, Lyon, France."},{"key":"key\n\t\t\t\t20171011160002_DDI052C2","doi-asserted-by":"crossref","unstructured":"Wooster, R. and Weber, B.L. ( 2003 ) Breast and ovarian cancer. N. Engl. J. Med. , 348 , 2339 \u20132347.","DOI":"10.1056\/NEJMra012284"},{"key":"key\n\t\t\t\t20171011160002_DDI052C3","doi-asserted-by":"crossref","unstructured":"King, M.-C., Marks, J.R., Mandell, J.B. and The New York Breast Cancer Study Group. ( 2003 ) Risks of breast and ovarian cancer due to inherited mutations in BRCA1 and BRCA2 . Science , 302 , 643 \u2013646.","DOI":"10.1126\/science.1088759"},{"key":"key\n\t\t\t\t20171011160002_DDI052C4","doi-asserted-by":"crossref","unstructured":"Nathanson, K.L. and Weber, B.L. ( 2001 ) \u2018Other\u2019 breast cancer susceptibility genes: searching for more holy grail. Hum. Mol. Genet. , 10 , 715 \u2013720.","DOI":"10.1093\/hmg\/10.7.715"},{"key":"key\n\t\t\t\t20171011160002_DDI052C5","doi-asserted-by":"crossref","unstructured":"Narod, S.A. ( 2002 ) Modifiers of risk of hereditary breast and ovarian cancer. Nat. Rev. Cancer , 2 , 113 \u2013123.","DOI":"10.1038\/nrc726"},{"key":"key\n\t\t\t\t20171011160002_DDI052C6","doi-asserted-by":"crossref","unstructured":"Antoniou, A.C., Pharoah, P.D., McMullan, G., Day, N.E., Ponder, B.A. and Easton, D. ( 2001 ) Evidence for further breast cancer susceptibility genes in addition to BRCA1 and BRCA2 in a population-based study. Genet. Epidemiol. , 21 , 1 \u201318.","DOI":"10.1002\/gepi.1014"},{"key":"key\n\t\t\t\t20171011160002_DDI052C7","doi-asserted-by":"crossref","unstructured":"Cui, J., Antoniou, A.C., Dite, G.S., Southe, M.C., Venter, D.J., Easton, D.F., Giles, G.G., McCredie, M.R. and Hopper J.L. ( 2001 ) After BRCA1 and BRCA2 -what next? Multifactorial segregation analyses of three-generation, population-based Australian families affected by female breast cancer. Am. J. Hum. Genet. , 68 , 420 \u2013431.","DOI":"10.1086\/318187"},{"key":"key\n\t\t\t\t20171011160002_DDI052C8","doi-asserted-by":"crossref","unstructured":"Matsuoka, S., Huang, M. and Elledge, S.J. ( 1998 ) Linkage of ATM to cell cycle regulation by the Chk2 protein kinase. Science , 282 , 1893 \u20131897.","DOI":"10.1126\/science.282.5395.1893"},{"key":"key\n\t\t\t\t20171011160002_DDI052C9","doi-asserted-by":"crossref","unstructured":"Brown, A.L., Lee, C.H., Schwarz, J.K., Mitiku, N., Piwnica-Worms, H. and Chung, J.H. ( 1999 ) A human Cds1-related kinase that functions downstream of ATM protein in the cellular response to DNA damage. Proc. Natl Acad. Sci. USA , 96 , 3745 \u20133750.","DOI":"10.1073\/pnas.96.7.3745"},{"key":"key\n\t\t\t\t20171011160002_DDI052C10","doi-asserted-by":"crossref","unstructured":"Lee, J.H. and Paull, T.T. ( 2004 ) Direct activation of the ATM protein kinase by the Mre11\/Rad50\/Nbs1 complex. Science , 304 , 93 \u201396.","DOI":"10.1126\/science.1091496"},{"key":"key\n\t\t\t\t20171011160002_DDI052C11","doi-asserted-by":"crossref","unstructured":"Lee, J.S., Collins, K.M., Brown, A.L., Lee, C.H. and Chung, J.H. ( 2000 ) hCds1-mediated phosphorylation of BRCA1 regulates the DNA damage response. Nature , 404 , 201 \u2013204.","DOI":"10.1038\/35004614"},{"key":"key\n\t\t\t\t20171011160002_DDI052C12","doi-asserted-by":"crossref","unstructured":"Zhang, J., Willers, H., Feng, Z., Ghosh, J.C., Kim, S., Weaver, D.T., Chung, J.H., Powell, S.N. and Xia, F. ( 2004 ) Chk2 phosphorylation of BRCA1 regulates DNA double-strand break repair. Mol. Cell. Biol. , 24 , 708 \u2013718.","DOI":"10.1128\/MCB.24.2.708-718.2004"},{"key":"key\n\t\t\t\t20171011160002_DDI052C13","doi-asserted-by":"crossref","unstructured":"Bell, D.W., Varley, J.M., Szydlo, T.E., Kang, D.H., Wahrer, D.C., Shannon, K.E., Lubratovich, M., Verselis, S.J., Isselbacher, K.J., Fraumeni, J.F. et\u00a0al. ( 1999 ) Heterozygous germ line h CHK2 mutations in Li\u2013Fraumeni syndrome. Science , 286 , 2528 \u20132531.","DOI":"10.1126\/science.286.5449.2528"},{"key":"key\n\t\t\t\t20171011160002_DDI052C14","doi-asserted-by":"crossref","unstructured":"Meijers-Heijboer, H., vandenOuweland, A., Klijn, J., Wasielewski, M., deSnoo, A., Oldenburg, R., Hollestelle, A., Houben, M., Crepin, E., vanVeghel-Plandsoen, M. et\u00a0al. ( 2002 ) CHEK2 -Breast Cancer Consortium. Low-penetrance susceptibility to breast cancer due to CHEK2*1100delC in non-carriers of BRCA1 or BRCA2 mutations. Nat. Genet. , 31 , 55 \u201359.","DOI":"10.1038\/ng879"},{"key":"key\n\t\t\t\t20171011160002_DDI052C15","doi-asserted-by":"crossref","unstructured":"Vahteristo, P., Bartkova, J., Eerola, H., Syrjakoski, K., Ojala, S., Kilpivaara, O., Tamminen, A., Kononen, J., Aittomaki, K., Heikkila, P. et\u00a0al. ( 2002 ) A CHEK2 genetic variant contributing to a substantial fraction of familial breast cancer. Am. J. Hum. Genet. , 71 , 432 \u2013438.","DOI":"10.1086\/341943"},{"key":"key\n\t\t\t\t20171011160002_DDI052C16","doi-asserted-by":"crossref","unstructured":"Offit, K., Pierce, H., Kirchhoff, T., Kolachana, P., Rapaport, B., Gregersen, P., Johnson, S., Yossepowitch, O., Huang, H., Satagopan, J. et\u00a0al. ( 2003 ) Frequency of CHEK2*1100delC in New York breast cancer cases and controls. BMC Med. Genet. , 4 , 1 .","DOI":"10.1186\/1471-2350-4-1"},{"key":"key\n\t\t\t\t20171011160002_DDI052C17","unstructured":"Lee, S.B., Kim, S.H., Bell, D.W., Wahrer, D.C., Schiripo, T.A., Jorczak, M.M., Sgroi, D.C., Garber, J.E., Li, F.P., Nichols, K.E. et\u00a0al. ( 2001 ) Destabilization of CHK2 by a missense mutation associated with Li\u2013Fraumeni syndrome. Cancer Res. , 61 , 8062 \u20138067."},{"key":"key\n\t\t\t\t20171011160002_DDI052C18","doi-asserted-by":"crossref","unstructured":"Allinen, M., Huusko, P., Mantyniemi, S., Launonen, V. and Winqvist, R. ( 2001 ) Mutation analysis of the CHK2 gene in families with hereditary breast cancer. Br. J. Cancer , 85 , 209 \u2013212.","DOI":"10.1054\/bjoc.2001.1858"},{"key":"key\n\t\t\t\t20171011160002_DDI052C19","doi-asserted-by":"crossref","unstructured":"Sodha, N., Bullock, S., Taylor, R., Mitchell, G., Guertl-Lackner, B., Williams, R.D., Bevan, S., Bishop, K., McGuire, S., Houlston, R.S. and Eeles, R.A. ( 2002 ) CHEK2 variants in susceptibility to breast cancer and evidence of retention of the wild type allele in tumours. Br. J. Cancer , 87 , 1445 \u20131448.","DOI":"10.1038\/sj.bjc.6600637"},{"key":"key\n\t\t\t\t20171011160002_DDI052C20","doi-asserted-by":"crossref","unstructured":"Schutte, M., Seal, S., Barfoot, R., Meijers-Heijboer, H., Wasielewski, M., Evans, D.G., Eccles, D., Meijers, C., Lohman, F., Klijn, J. et\u00a0al. ( 2003 ) Variants in CHEK2 other than 1100delC do not make a major contribution to breast cancer susceptibility. Am. J. Hum. Genet. , 72 , 1023 \u20131028.","DOI":"10.1086\/373965"},{"key":"key\n\t\t\t\t20171011160002_DDI052C21","doi-asserted-by":"crossref","unstructured":"Kilpivaara, O., Vahteristo, P., Falck, J., Syrjakoski, K., Eerola, H., Easton, D., Bartkova, J., Lukas, J., Heikkila, P., Aittomaki, K. et\u00a0al. ( 2004 ) CHEK2 variant I157T may be associated with increased breast cancer risk. Int. J. Cancer , 111 , 543 \u2013547.","DOI":"10.1002\/ijc.20299"},{"key":"key\n\t\t\t\t20171011160002_DDI052C22","doi-asserted-by":"crossref","unstructured":"Cybulski, C., Gorski, B., Huzarski, T., Masojc, B., Mierzejewski, M., Debniak, T., Teodorczyk, U., Byrski, T., Gronwald, J., Matyjasik, J. et\u00a0al. ( 2004 ) CHEK2 is a multi-organ cancer susceptibility gene. Am. J. Hum. Genet. , 75 , 1131 \u20131135.","DOI":"10.1086\/426403"},{"key":"key\n\t\t\t\t20171011160002_DDI052C23","doi-asserted-by":"crossref","unstructured":"Chatterjee, N., Hartge, P. and Wacholder, S. ( 2003 ) Adjustment for competing risk in kin-cohort estimation. Genet. Epidemiol. , 25 , 303 \u2013313.","DOI":"10.1002\/gepi.10269"},{"key":"key\n\t\t\t\t20171011160002_DDI052C24","doi-asserted-by":"crossref","unstructured":"Ostrer, H. ( 2001 ) A genetic profile of contemporary Jewish populations. Nat. Rev. Genet. , 2 , 891 \u2013898.","DOI":"10.1038\/35098506"},{"key":"key\n\t\t\t\t20171011160002_DDI052C25","doi-asserted-by":"crossref","unstructured":"Risch, N., Tang, H., Katzenstein, H. and Ekstein, J. ( 2003 ) Geographic distribution of disease mutations in the Ashkenazi Jewish population supports genetic drift over selection. Am. J. Hum. Genet. , 72 , 812 \u2013822.","DOI":"10.1086\/373882"},{"key":"key\n\t\t\t\t20171011160002_DDI052C26","doi-asserted-by":"crossref","unstructured":"Struewing, J.P., Abeliovich, D., Peretz, T., Avishai, N., Kaback, M.M., Collins, F.S. and Brody L.C. ( 1995 ) The carrier frequency of the BRCA1 185delAG mutation is approximately 1 percent in Ashkenazi Jewish individuals. Nat. Genet. , 11 , 198 \u2013200.","DOI":"10.1038\/ng1095-198"},{"key":"key\n\t\t\t\t20171011160002_DDI052C27","doi-asserted-by":"crossref","unstructured":"Oddoux, C., Struewing, J.P., Clayton, C.M., Neuhausen, S., Brody, L.C., Kaback, M., Haas, B., Norton, L., Borgen, P., Jhanwar, S. et\u00a0al. ( 1996 ) The carrier frequency of the BRCA2 6174delT mutation among Ashkenazi Jewish individuals is approximately 1%. Nat. Genet. , 14 , 188 \u2013190.","DOI":"10.1038\/ng1096-188"},{"key":"key\n\t\t\t\t20171011160002_DDI052C28","unstructured":"Levy-Lahad, E., Catane, R., Eisenberg, S., Kaufman, B., Hoeich, G., Lishinsky, E., Shohat, M., Weber, B.L., Beller, U., Lahad, A. et\u00a0al. ( 1997 ) Founder BRCA1 and BRCA2 mutations in Ashkenazi Jews in Israel: frequency and differential penetrance in ovarian cancer and in breast\u2013ovarian cancer families. Am. J. Hum. Genet. , 60 , 1059 \u20131067."},{"key":"key\n\t\t\t\t20171011160002_DDI052C29","doi-asserted-by":"crossref","unstructured":"Kauff, N.D., Perez-Segura, P., Robson, M.E., Scheuer, L., Siegel, B., Schluger, A., Rapaport, B., Frank, T.S., Nafa, K., Ellis, N.A. et\u00a0al. ( 2002 ) Incidence of non-founder BRCA1 and BRCA2 mutations in high risk Ashkenazi breast and ovarian cancer families. J. Med. Genet. , 39 , 611 \u2013614.","DOI":"10.1136\/jmg.39.8.611"},{"key":"key\n\t\t\t\t20171011160002_DDI052C30","doi-asserted-by":"crossref","unstructured":"Neuhausen, S., Dunning, A., Steele, L., Yakumo, K., Hoffman, M., Szabo, C., Tee, L., Baines, C., Pharoah, P., Goldgar, D. and Easton, D. ( 2004 ) Role of CHEK2*1100delC in unselected series of non- BRCA1 \/2 male breast cancers. Int. J. Cancer , 108 , 477 \u2013478.","DOI":"10.1002\/ijc.11385"},{"key":"key\n\t\t\t\t20171011160002_DDI052C31","doi-asserted-by":"crossref","unstructured":"Ohayon, T., Gal, I., Baruch, R.G., Szabo, C. and Friedman, E. ( 2004 ) CHEK2*1100delC and male breast cancer risk in Israel. Int. J. Cancer , 108 , 479 \u2013480.","DOI":"10.1002\/ijc.11603"},{"key":"key\n\t\t\t\t20171011160002_DDI052C32","unstructured":"Oldenburg, R.A., Kroeze-Jansema, K., Kraan, J., Morreau, H., Klijn, J.G., Hoogerbrugge, N., Ligtenberg, M.J., vanAsperen, C.J., Vasen, H.F., Meijers, C. et\u00a0al. ( 2003 ) The CHEK2 *1100delC variant acts as a breast cancer risk modifier in non- BRCA1 \/ BRCA2 multiple-case families. Cancer Res. , 63 , 8153 \u20138157."},{"key":"key\n\t\t\t\t20171011160002_DDI052C33","doi-asserted-by":"crossref","unstructured":"Dawson, E., Abecasis, G.R., Bumpstead, S., Chen, Y., Hunt, S., Beare, D.M., Pabial, J., Dibling, T., Tinsley, E., Kirby, S. et\u00a0al. ( 2002 ) A first-generation linkage disequilibrium map of human chromosome 22. Nature , 418 , 544 \u2013548.","DOI":"10.1038\/nature00864"},{"key":"key\n\t\t\t\t20171011160002_DDI052C34","doi-asserted-by":"crossref","unstructured":"Kriege, M., Brekelmans, C.T., Boetes, C., Besnard, P.E., Zonderland, H.M., Obdeijn, I.M., Manoliu, R.A., Kok, T., Peterse, H., Tilanus-Linthorst, M.M. et\u00a0al. , for the Magnetic Resonance Imaging Screening Study Group. ( 2004 ) Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition. N. Engl. J. Med. , 351 , 427 \u2013437.","DOI":"10.1056\/NEJMoa031759"},{"key":"key\n\t\t\t\t20171011160002_DDI052C35","doi-asserted-by":"crossref","unstructured":"Warner, E., Plewes, D.B., Hill, K.A., Causer, P.A., Zubovits, J.T., Jong, R.A., Cutrara, M.R., DeBoer, G., Yaffe, M.J., Messner, S.J. et\u00a0al. ( 2004 ) Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination. J. Am. Med. Assoc. , 292 , 1317 \u20131325.","DOI":"10.1001\/jama.292.11.1317"},{"key":"key\n\t\t\t\t20171011160002_DDI052C36","doi-asserted-by":"crossref","unstructured":"Burke, W., Daly, M., Garber, J., Botkin, J., Kahn, M.J., Lynch, P., McTiernan, A., Offit, K., Perlman, J., Petersen, G. et\u00a0al. ( 1997 ) Recommendations for follow-up care of individuals with an inherited predisposition to cancer. II. BRCA1 and BRCA2 . Cancer Genetics Studies Consortium. J. Am. Med. Assoc. , 277 , 997 \u20131003.","DOI":"10.1001\/jama.1997.03540360065034"},{"key":"key\n\t\t\t\t20171011160002_DDI052C37","doi-asserted-by":"crossref","unstructured":"Meijers-Heijboer, H., van Geel, B., van Putten, W.L., Henzen-Logmans, S.C., Seynaeve, C., Menke-Pluymers, M.B., Bartels, C.C., Verhoog, L.C., van den Ouweland, A.M., Niermeijer, M.F. et\u00a0al. ( 2001 ) Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutation. N. Engl. J. Med. , 345 , 159 \u2013164.","DOI":"10.1056\/NEJM200107193450301"},{"key":"key\n\t\t\t\t20171011160002_DDI052C38","doi-asserted-by":"crossref","unstructured":"Kauff, N.D., Satagopan, J.M., Robson, M.E., Scheuer, L., Hensley, M., Hudis, C.A., Ellis, N.A., Boyd, J., Borgen, P.I., Barakat, R.R. et\u00a0al. ( 2002 ) Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation. N. Engl. J. Med. , 346 , 1609 \u20131615.","DOI":"10.1056\/NEJMoa020119"},{"key":"key\n\t\t\t\t20171011160002_DDI052C39","doi-asserted-by":"crossref","unstructured":"Levy-Lahad, E., Lahad, A., Eisenberg, S., Dagan, E., Paperna, T., Kasinetz, L., Catane, R., Kaufman, B., Beller, U., Renbaum, P. and Gershoni-Baruch, R. ( 2001 ) A single nucleotide polymorphism in the RAD51 gene modifies cancer risk in BRCA2 but not BRCA1 carriers. Proc. Natl Acad. Sci. USA , 98 , 3232 \u20133236.","DOI":"10.1073\/pnas.051624098"},{"key":"key\n\t\t\t\t20171011160002_DDI052C41","doi-asserted-by":"crossref","unstructured":"Matchell, M.K., Gregersen, P.K., Johnson, S., Parsons, R. and Vlahov, D. ( 2004 ) The New York Cancer Project: rationale, organization, design, and baseline characteristics. J. Urban Health , 81 , 301 \u2013310.","DOI":"10.1093\/jurban\/jth116"},{"key":"key\n\t\t\t\t20171011160002_DDI052C40","doi-asserted-by":"crossref","unstructured":"Newman, B., Mu, H., Butler, L.M., Millikan, R.C., Moorman, P.G. and King, M.C. ( 1998 ) Frequency of breast cancer attributable to BRCA1 in a population-based series of American women. J. Am. Med. Assoc. , 279 , 915 \u2013921.","DOI":"10.1001\/jama.279.12.915"},{"key":"key\n\t\t\t\t20171011160002_DDI052C42","doi-asserted-by":"crossref","unstructured":"Sodha, N., Williams, R., Mangion, J., Bullock, S.L., Yuille, M.R. and Eeles, R.A. ( 2000 ) Screening hCHK2 for mutations. Science , 289 , 359 .","DOI":"10.1126\/science.289.5478.359a"},{"key":"key\n\t\t\t\t20171011160002_DDI052C43","unstructured":"Weir, B.S. ( 1996 ) Genetic Data Analysis II. Sinauer Associates, Sunderland, MA."}],"container-title":["Human Molecular Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/hmg\/article-pdf\/14\/4\/555\/6949451\/ddi052.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,5]],"date-time":"2020-04-05T09:30:55Z","timestamp":1586079055000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/hmg\/article\/14\/4\/555\/2355842\/Functional-and-genomic-approaches-reveal-an"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,1,13]]},"references-count":43,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2005,1,13]]},"published-print":{"date-parts":[[2005,2,15]]}},"URL":"https:\/\/doi.org\/10.1093\/hmg\/ddi052","relation":{},"ISSN":["1460-2083","0964-6906"],"issn-type":[{"value":"1460-2083","type":"electronic"},{"value":"0964-6906","type":"print"}],"subject":[],"published-other":{"date-parts":[[2005,2,15]]},"published":{"date-parts":[[2005,1,13]]}}}